Wei Zhimeng, Zhang Shuai, Wang Xingya, Bai Jie, Wang Hui, Yang Yuanchao, Zhai Jingbo
School of Basic Medical Sciences, Inner Mongolia Minzu University, Tongliao, China.
Department of Clinical Laboratory, Keerqin District First People's Hospital, Tongliao, China.
Front Microbiol. 2025 Jun 18;16:1608617. doi: 10.3389/fmicb.2025.1608617. eCollection 2025.
is an intracellular parasitic bacterium with a wide host range. It can infect terrestrial mammals, including domestic animals such as cattle and sheep, as well as wild animals like elk and bison. It also infects marine mammals, and amphibians. These diverse hosts form the basis for the classification of into different species. It can invade multiple cell types, including human cells such as monocytes/macrophages, dendritic cells (DCs), and trophoblasts; primary animal cells such as murine and bovine macrophages, and canine trophoblasts; and established cell lines such as HeLa and Vero cells. Among these, macrophages, DCs, and trophoblasts are the main target cells. employs a variety of strategies to evade host defenses: (1) obstruction of pattern recognition receptors; (2) formation of replicative -containing vacuoles following entry into host cells; (3) suppression of innate immunity through manipulation of autophagy, endoplasmic reticulum stress, inflammasomes, pyroptosis, apoptosis, ferroptosis, and pathways including cGAS-STING; and (4) inhibition of adaptive immunity through reduced antigen presentation. Compromised innate and adaptive immunity allows to replicate and survive within host cells, leading to chronic infections that are difficult to eradicate. Notably, suppresses host immunity by producing virulence factors that inhibit cytokine release and antigen presentation, and that interfere with critical signaling pathways such as programed cell death, ultimately downregulating both innate and adaptive immune responses. Collectively, these features have made the development of treatments and vaccines for brucellosis particularly challenging. While a better understanding of virulence factors is key to the effective prevention and control of brucellosis, many pathogenic mechanisms remain unclear. In this systematic review, we focus on the interactions between and the host immune system. Specifically, we examine the roles of the following factors in infection: lipopolysaccharides, flagella, the type IV secretion system (T4SS), effector proteins secreted by the T4SSs and non-T4SS, outer membrane proteins, phosphatidylcholine, mechanisms of intracellular survival, pathogen-associated molecular patterns, pattern recognition receptors, subversion of selective autophagy, endoplasmic reticulum stress pathways, inflammasomes, pyroptosis, apoptosis, ferroptosis, and the cGAS-STING pathway. We anticipate that this overview will offer new insights for research and development into drugs and vaccines for brucellosis.
是一种细胞内寄生细菌,宿主范围广泛。它可感染陆生哺乳动物,包括牛和羊等家畜,以及麋鹿和野牛等野生动物。它还感染海洋哺乳动物和两栖动物。这些不同的宿主构成了将其分类为不同物种的基础。它可侵入多种细胞类型,包括人类细胞,如单核细胞/巨噬细胞、树突状细胞(DCs)和滋养层细胞;原代动物细胞,如小鼠和牛的巨噬细胞以及犬类滋养层细胞;以及已建立的细胞系,如HeLa细胞和Vero细胞。其中,巨噬细胞、DCs和滋养层细胞是主要靶细胞。采用多种策略逃避宿主防御:(1)阻碍模式识别受体;(2)进入宿主细胞后形成含复制泡;(3)通过操纵自噬、内质网应激、炎性小体、细胞焦亡、凋亡、铁死亡以及包括cGAS-STING在内的信号通路来抑制先天免疫;(4)通过减少抗原呈递来抑制适应性免疫。先天免疫和适应性免疫受损使得能够在宿主细胞内复制和存活,导致难以根除的慢性感染。值得注意的是,通过产生抑制细胞因子释放和抗原呈递、干扰程序性细胞死亡等关键信号通路的毒力因子来抑制宿主免疫,最终下调先天免疫和适应性免疫反应。总体而言,这些特征使得布鲁氏菌病治疗方法和疫苗的研发极具挑战性。虽然更好地了解毒力因子是有效预防和控制布鲁氏菌病的关键,但许多致病机制仍不清楚。在本系统综述中,我们聚焦于与宿主免疫系统之间的相互作用。具体而言,我们研究以下因素在感染中的作用:脂多糖、鞭毛、IV型分泌系统(T4SS)、T4SS和非T4SS分泌的效应蛋白、外膜蛋白、磷脂酰胆碱、细胞内存活机制、病原体相关分子模式、模式识别受体、选择性自噬的颠覆、内质网应激通路、炎性小体、细胞焦亡、凋亡、铁死亡以及cGAS-STING通路。我们预计本综述将为布鲁氏菌病药物和疫苗的研发提供新的见解。